title: Reply to the letter to the editor 'treating breast cancer with trabectedin: a new arsenal' by L. Malik.
authors: Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. Electronic address: suzette.delaloge@gustaveroussy.fr.
authors: S
authors: S
authors: Delaloge
authors: Pharma Mar SA, Barcelona, Spain.
authors: M
authors: M
authors: Cullell-Young
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004149:Dioxoles / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D004149:Dioxoles; D044005:Tetrahydroisoquinolines